FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048475963> ?p ?o ?g. }

• W2048475963 endingPage "797" @default.
• W2048475963 startingPage "793" @default.
• W2048475963 abstract "Lactoferrin, an innate defense iron-binding protein, possesses antimicrobial and anti-inflammatory activities. Beneficial systemic effects on inflammatory diseases have been proposed. The aim of the present study was to explore the efficacy and tolerability of oral bovine lactoferrin supplementation in subjects with mild to moderate facial acne vulgaris.In this open-label, single-arm study, 43 adolescents and young adults were enrolled to take a chewable tablet formulation of bovine lactoferrin twice daily for 8 weeks. The primary efficacy endpoint was the improvement in acne lesion counts compared with baseline. Tolerability was evaluated on the basis of adverse event frequencies.Thirty-nine subjects, aged 17.5 ± 3.8 years, completed the study per protocol. At the end of the study (week 8), a mean reduction in inflammatory lesion count of 20.2% (-2.2 ± 7.0, p = 0.054), in non-inflammatory lesion count of 23.5% (-6.2 ± 9.8, p < 0.001), and in total lesion count of 22.5% (-8.4 ± 13.1, p < 0.001) was observed as compared with baseline. At study conclusion, 76.9% (30 of 39) of subjects showed a reduction in total lesion count. The results for inflammatory acne lesions were variable over the study course. None of the subjects experienced a lactoferrin-related adverse event during the trial.Despite the limitations of an uncontrolled, open-label study, the results from this study indicate that lactoferrin in mild to moderate acne vulgaris is well tolerated and may lead to an overall improvement in acne lesion counts in the majority of affected adolescents and young adults when administered as a dietary supplement on a twice daily regimen. Further randomized, placebo-controlled trials of longer duration appear warranted." @default.
• W2048475963 created "2016-06-24" @default.
• W2048475963 creator A5051904942 @default.
• W2048475963 creator A5053155088 @default.
• W2048475963 creator A5081092789 @default.
• W2048475963 creator A5085445476 @default.
• W2048475963 creator A5035993362 @default.
• W2048475963 date "2011-04-01" @default.
• W2048475963 modified "2023-09-24" @default.
• W2048475963 title "Efficacy and tolerability of oral lactoferrin supplementation in mild to moderate acne vulgaris: an exploratory study" @default.
• W2048475963 cites W1569631805 @default.
• W2048475963 cites W1964657789 @default.
• W2048475963 cites W1969646674 @default.
• W2048475963 cites W1971372468 @default.
• W2048475963 cites W1976487421 @default.
• W2048475963 cites W1980543825 @default.
• W2048475963 cites W1998974794 @default.
• W2048475963 cites W2033036174 @default.
• W2048475963 cites W2033397348 @default.
• W2048475963 cites W2034935527 @default.
• W2048475963 cites W2044008959 @default.
• W2048475963 cites W2050523894 @default.
• W2048475963 cites W2052172283 @default.
• W2048475963 cites W2057469247 @default.
• W2048475963 cites W2058337019 @default.
• W2048475963 cites W2064475470 @default.
• W2048475963 cites W2070788384 @default.
• W2048475963 cites W2078660736 @default.
• W2048475963 cites W2085050267 @default.
• W2048475963 cites W2093065112 @default.
• W2048475963 cites W2108686952 @default.
• W2048475963 cites W2119657344 @default.
• W2048475963 cites W2122476363 @default.
• W2048475963 cites W2158366771 @default.
• W2048475963 cites W2172197291 @default.
• W2048475963 cites W2328409626 @default.
• W2048475963 cites W2469414933 @default.
• W2048475963 cites W3006134497 @default.
• W2048475963 cites W744842430 @default.
• W2048475963 doi "https://doi.org/10.1185/03007995.2011.557720" @default.
• W2048475963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21303195" @default.
• W2048475963 hasPublicationYear "2011" @default.
• W2048475963 type Work @default.
• W2048475963 sameAs 2048475963 @default.
• W2048475963 citedByCount "14" @default.
• W2048475963 countsByYear W20484759632012 @default.
• W2048475963 countsByYear W20484759632013 @default.
• W2048475963 countsByYear W20484759632014 @default.
• W2048475963 countsByYear W20484759632017 @default.
• W2048475963 countsByYear W20484759632019 @default.
• W2048475963 countsByYear W20484759632020 @default.
• W2048475963 countsByYear W20484759632021 @default.
• W2048475963 countsByYear W20484759632022 @default.
• W2048475963 countsByYear W20484759632023 @default.
• W2048475963 crossrefType "journal-article" @default.
• W2048475963 hasAuthorship W2048475963A5035993362 @default.
• W2048475963 hasAuthorship W2048475963A5051904942 @default.
• W2048475963 hasAuthorship W2048475963A5053155088 @default.
• W2048475963 hasAuthorship W2048475963A5081092789 @default.
• W2048475963 hasAuthorship W2048475963A5085445476 @default.
• W2048475963 hasConcept C126322002 @default.
• W2048475963 hasConcept C141071460 @default.
• W2048475963 hasConcept C142724271 @default.
• W2048475963 hasConcept C16005928 @default.
• W2048475963 hasConcept C197934379 @default.
• W2048475963 hasConcept C203092338 @default.
• W2048475963 hasConcept C204787440 @default.
• W2048475963 hasConcept C27081682 @default.
• W2048475963 hasConcept C2777673923 @default.
• W2048475963 hasConcept C2778375690 @default.
• W2048475963 hasConcept C2779170986 @default.
• W2048475963 hasConcept C2781156865 @default.
• W2048475963 hasConcept C535046627 @default.
• W2048475963 hasConcept C54355233 @default.
• W2048475963 hasConcept C71924100 @default.
• W2048475963 hasConcept C86803240 @default.
• W2048475963 hasConcept C90924648 @default.
• W2048475963 hasConceptScore W2048475963C126322002 @default.
• W2048475963 hasConceptScore W2048475963C141071460 @default.
• W2048475963 hasConceptScore W2048475963C142724271 @default.
• W2048475963 hasConceptScore W2048475963C16005928 @default.
• W2048475963 hasConceptScore W2048475963C197934379 @default.
• W2048475963 hasConceptScore W2048475963C203092338 @default.
• W2048475963 hasConceptScore W2048475963C204787440 @default.
• W2048475963 hasConceptScore W2048475963C27081682 @default.
• W2048475963 hasConceptScore W2048475963C2777673923 @default.
• W2048475963 hasConceptScore W2048475963C2778375690 @default.
• W2048475963 hasConceptScore W2048475963C2779170986 @default.
• W2048475963 hasConceptScore W2048475963C2781156865 @default.
• W2048475963 hasConceptScore W2048475963C535046627 @default.
• W2048475963 hasConceptScore W2048475963C54355233 @default.
• W2048475963 hasConceptScore W2048475963C71924100 @default.
• W2048475963 hasConceptScore W2048475963C86803240 @default.
• W2048475963 hasConceptScore W2048475963C90924648 @default.
• W2048475963 hasIssue "4" @default.
• W2048475963 hasLocation W20484759631 @default.
• W2048475963 hasLocation W20484759632 @default.
• W2048475963 hasOpenAccess W2048475963 @default.

• next